CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets

Blood

Volumn 111, Issue 7, 2008, Pages 3626-3634

  Bernardini, Giovanni ^a   Sciume, Giuseppe ^a   Bosisio, Daniela ^b   Morrone, Stefania ^a   Sozzani, Silvano ^b   Santoni, Angela ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CCL3 PROTEIN, MOUSE; CCR1 PROTEIN, MOUSE; CXCL10 PROTEIN, MOUSE; CXCL12 PROTEIN, MOUSE; CXCR3 PROTEIN, MOUSE; CXCR4 PROTEIN, MOUSE; HETEROCYCLIC COMPOUND;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL MATURATION; CELL MIGRATION; CELL POPULATION; CELL SUBPOPULATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IN VITRO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SPLEEN CELL; ANIMAL; ANTIBODY SPECIFICITY; CELL MOTION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; IMMUNOLOGY; STEM CELL;

ANIMALS; ANTI-HIV AGENTS; BONE MARROW CELLS; CELL MOVEMENT; CHEMOKINE CCL3; CHEMOKINE CXCL10; CHEMOKINE CXCL12; GENE EXPRESSION REGULATION; HETEROCYCLIC COMPOUNDS; KILLER CELLS, NATURAL; MICE; ORGAN SPECIFICITY; RECEPTORS, CCR1; RECEPTORS, CXCR3; RECEPTORS, CXCR4; STEM CELLS;

EID: 43549127172     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-08-106203     Document Type: Article

References (50)

1. Lodoen MB, Lanier LL. Natural killer cells as an initial defense against pathogens. Curr Opin Immunol. 2006;18:391-398.
2. French AR, Yokoyama WM. Natural killer cells and viral infections. Curr Opin Immunol. 2003;15:45-51.
3. Gasser S, Raulet D. The DNAdamage response, immunity and cancer. Semin Cancer Biol. 2006;16:344-347.
4. Roth C, Rothlin C, Riou S, Raulet DH, Lemke G. Stromal-cell regulation of natural killer cell differentiation. J Mol Med. 2007;85:1047-1056.
5. Colucci F, Caligiuri MA, Di Santo J P. What does ittake to make a natural killer? Nat Rev Immunol. 2003;3:413-425.
6. Di Santo J P. Natural killer cell developmental pathways: a question of balance. Annu Rev Immunol. 2006;24:257-286.
7. Yokoyama WM, Kim S, French AR. The dynamic life of natural killer cells. Annu Rev Immunol. 2004;22:405-429.
8. KawamuraT, Koka R, Ma A, Kumar V. Differential roles for IL-15R alpha-chain in NKcell development and Ly-49 induction. J Immunol. 2003;171:5085-5090.
9. Kim S, lizuka K, Kang HS, et al. In vivo developmental stages in murine natural killer cell maturation. Nat Immunol. 2002;3:523-528.
10. Hayakawa Y, Huntington ND, Nutt SL, Smyth MJ. Functional subsets of mouse natural killer cells. Immunol Rev. 2006;214:47-55.
11. Takeda K, Cretney E, Hayakawa Y, et al. TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver. Blood. 2005;105:2082-2089.
12. Vosshenrich CA. Garcia-Ojeda ME, Samson-Villeger SI, et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat Immunol. 2006;7:1217-1224.
13. Campbell DJ, Kim CH, Butcher EC. Chemokines in the systemic organization of immunity. Immunol Rev. 2003;195:58-71.
14. MantovaniA, Bonecchi R, Locati M.Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol. 2006;6:907-918.
15. Sozzani S. Dendritic cell trafficking: more than just chemokines. Cytokine Growth Factor Rev. 2005;16:581-592.
16. Nagasawa T. Microenvironmental niches in the bone marrow required for B-cell development. Nat Rev Immunol. 2006;6:107-116.
17. Stein JV, Nornbela-Arrieta C. Ghemokine control of lymphocyte trafficking: a general overview. Immunology. 2005;116:1-12.
18. Martin C, Burdon PC, BridgerG, Gutierrez-Ramos JC, Williams TJ, Rankin SM. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity. 2003;19:583-593.
19. Grassi F, Piacentini A, Cristino S. et al. Human osteoclasts express different CXC chemokines depending on cell culture substrate: molecular and immunocytochemical evidence of high levels of CXCUOand CXCL12. Histochem Cell Biol. 2003;120:391-400.
20. Jarmin DI, Nibbs RJ, Jamieson T, de Bono JS, Graham GJ. Granulocyte macrophage colony-stimulating factor and interleukin-3 regulate chemokine and chemokine receptor expression in bone marrow macrophages. Exp Hematol. 1999;27:1735-1745.
21. Lean JM, Murphy C, Fuller K, Chambers TJ. CCL9/MIP-1gammaand its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts. J Cell Biochem. 2002;87:386-393.
22. Gismondi A, Santoni A. Migration of NK cells. In: Badolato R, Sozzani S, eds. Lymphocyte Trafficking in Health and Disease. Basel, Switzerland: BirkhauserVerlag;2006:95-112.
23. Walzer T, Chiossone L, Chaix J, et al. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol. 2007;12:1337-1344.
24. Salazar-MatherTP, Orange JS, Biron CA. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha(MIP-1alpha)-dependent pathways. J Exp Med. 1998;187:1-14.
25. Zeng X, Moore TA, Newstead MW, Hernandez-Alcoceba R, Tsai WC, Standiford TJ. Intrapulmonary expression of macrophage inflammatory protein 1 alpha (CCL3) induces neutrophil and NK cell accumulation and stimulates innate immunity in murine bacterial pneumonia. Infect Immun. 2003;71:1306-1315.
26. Shang X, Oiu B. Frait KA, Hu JS, et al. Chemokine receptor 1 knockout abrogates natural killer cell recruitment and impairs type-1 cytokines in lymphoid tissue during pulmonary granuloma formation. Am J Pathol. 2000;157:2055-2063.
27. Jiang D, Liang J, Hodge J, et al. Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J Clin Invest. 2004;114:291-299.
28. Martin-FontechaA, Thomsen LL, Brett S, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gammaforT(H)1 priming. Nat Immunol. 2004;5:1260-1265.
29. Ljunggren HG, Malmberg KJ. Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol. 2007;7:329-339.
30. Bernardini G, Kim JY, Gismondi A, Butcher EC, Santoni A. Chemoattractant induces LFA-1 associated PI 3K activity and cell migration that are dependent on Fyn signaling. FASEB J. 2005;19: 1305-1307.
31. Broxmeyer HE, Orschell CM, Clapp DW, et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AM D3100, a CXCR4 antagonist. J Exp Med. J Exp Med. 2005;201:1307-1318.
32. Broxmeyer HE, Cooper S, Hangoc G. Gao JL, Murphy PM. Dominant myelopoietic effector functions mediated by chemokine receptor CCR1. J Exp Med. 1999;189:1987-1992.
33. Benner RA, von Oudenaren GK. Induction of antibody formation in mouse bone marrow. In: Pernis B, Lefkovits I, eds. Immunological Methods. Vol 2. New York, NY: Academy Press;1981:247-267.
34. Bowman EP, Campbell JJ, Soler D, et al. Developmental switches in chemokine response profiles during B cell differentiation and maturation. J Exp Med. 2000;191:1303-1318.
35. osmaraki EE, Douagi I, Roth C. Colucci F, CumanoA, Di Santo J P. Identification of committed NK cell progenitors in adult murine bone marrow. EurJ Immunol. 2001;31:1900-1909.
36. Levesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest. 2003;111:187-196.
37. Christopherson KW II, Cooper S, Broxmeyer HE. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood. 2003;101:4680-4686.
38. DarA, Kollet O, Lapidot T. Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol. 2006;34:967-975.
39. SurattBT, Petty JM, Young SK, et al. Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis. Blood. 2004;104:565-571.
40. Hauser AE, Debes GF, Arce S, et al. Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the
41. time course of a memory immune response. J Immunol. 2002;169:1277-1282.
42. Bleul CC, Schultze JL Springer TA. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement. J Exp Med. 1998;187: 753-762.
43. Paoletti S, Petkovic V, Sebastiani S, Danelon MG;Uguccioni M, Gerber BO. A rich chemokine environment strongly enhances leukocyte migration and activities. Blood. 2005;105:3405-3412.
44. KrugA, Uppaluri R, Facchetti F. et al. IFN-producing cells respond to CXCR3 ligands in the presence of GXCL12 and secrete inflammatory chemokines upon activation. J Immunol. 2002;169:6079-6083.
45. Graham GJ;Wright EG, Hewick R, et al. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature. 1990;344:442-444.
46. Cooper S, Mantel C, Broxmeyer HE. Myelosup-pressive effects in vivo with very low dosages of monomeric recombinant murine macrophage inflammatory protein-1 alpha. Exp Hematol. 1994;22:186-193.
47. Jinquan T, Quan S, Jacobi HH. et al. CXC chemokine receptor 3 expression on CD34(+) hematopoietic progenitors from human cord blood induced by granulocyte-macrophage colony-stimulating factor: chemotaxis and adhesion induced by its ligands, interferon zamma-inducible protein 10 and monokine induced by interferon gamma. Blood. 2000;96: 1230-1238.
48. Marshall E, Woolford LB, Lord Bl. Continuous infusion of macrophage inflammatory protein MIP-1alpha enhances leucocyte recovery and haemopoietic progenitor cell mobilization after cyclophosphamide. Br J Cancer. 1997;75:1715-1720.
49. Barlic J, SechlerJM, Murphy PM. IL-15and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1. Blood. 003;102:3494-3503.
50. Wald O, Weiss ID, Wald H, et al. IFN-gamma acts on T cells to induce NK cell mobilization and accumulation in target organs. J Immunol. 2006;176:4716-4729.